Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Daniel J. Edelman Inc. dba Edelman on behalf of itself and its Affiliates
Johnson & Johnson highlights promising first-in-human Erda-iDRS (formerly TAR-210) results in intermediate-risk non-muscle-invasive bladder cancer
May 16, 2026
Johnson & Johnson investigational co-antibody therapy JNJ-4804 shows potential to raise the bar for clinical efficacy in treating refractory inflammatory bowel disease
May 16, 2026
Johnson & Johnson study shows TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to demonstrate efficacy in perianal fistulizing Crohn’s disease
May 16, 2026
ElevenLabs debuts ’11 Voices’ docuseries at SXSW as part of global campaign to reach 1 million people with voice loss
May 16, 2026
Bel Invests $200 Million to Double Babybel® Production Capacity in Brookings, South Dakota
May 16, 2026
TACO BELL® REVEALS ITS 2026 MENU INNOVATIONS AT LIVE MÁS LIVE: A NIGHT AT THE PALLADIUM – A STAR-POWERED HOLLYWOOD SPECTACLE, NOW STREAMING ON PEACOCK
May 16, 2026
Degree® Clinical 5X Deodorant Is On Sweat Defense at March Madness® with Chet Holmgren and Candace Parker
May 16, 2026
ICOTYDE™ (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once‑daily pill for plaque psoriasis
March 30, 2026
FDA approval of ICOTYDE™ (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide
March 18, 2026
Dove Champions Body Confidence and Girls’ Joy in Sports in Big Game Ad
January 30, 2026
←
Previous Page
1
…
4
5
6
7
8
…
13
Next Page
→